FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pressure Support Ventilation Versus Neurally Adjusted Ventilatory Assist in Difficult to Wean Pediatric Patients

Completed

Conditions: Weaning Failure
Distress Respiratory Syndrome

First Posted Date: 2020-04-24

Last Posted Date: 2021-10-06

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 12

Registration Number: NCT04360590

Autologous Tansfusion REquirements in Bone MArrow Harvest: The ATREMA Study

Completed

Conditions: Bone Marrow Donors

First Posted Date: 2020-04-21

Last Posted Date: 2023-02-16

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 7

Registration Number: NCT04355130

Locations: 🇮🇹
Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy

Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

Completed

Conditions: Atrial Fibrillation

Interventions: Drug: Edoxaban

First Posted Date: 2020-02-17

Last Posted Date: 2021-11-01

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 12

Registration Number: NCT04271293

Locations: 🇮🇹
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Lung Microbiota Analysis in Critically Ill Patients Admitted to the Intensive Care Unit.

Conditions: Lung Microbiota

First Posted Date: 2020-02-17

Last Posted Date: 2022-03-25

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 150

Registration Number: NCT04271345

Locations: 🇮🇹
Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy

NUVOLA TRIAL Open-label Multicentre Study

Phase 2

Conditions: High Grade Serous Ovarian Cancer

Interventions: Drug: Olaparib
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2020-02-07

Last Posted Date: 2020-02-07

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 35

Registration Number: NCT04261465

Locations: 🇮🇹
Fondazione Policlinico Gemelli IRCCS, Roma, Italy

PEEP and Spontaneous Breathing During ARDS

Not Applicable

Completed

Conditions: Acute Respiratory Distress Syndrome

Interventions: Other: Mechanical Ventilation

First Posted Date: 2020-01-27

Last Posted Date: 2022-09-07

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 16

Registration Number: NCT04241874

Locations: 🇮🇹
Fondazione Policlinico Universitaro A. Gemelli IRCCS, Rome, Italy

Single-lumen 5Fr and Triple-lumen 6Fr PICCs Are Accurate for Hemodynamic Measurement by Transpulmonary Thermodilution.

Not Applicable

Completed

Conditions: Centrally Inserted Central Catheter
Hemodynamic Monitoring
Peripherally Inserted Central Catheters
Transpulmonary Thermodilution

First Posted Date: 2020-01-27

Last Posted Date: 2020-07-23

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 15

Registration Number: NCT04241926

Locations: 🇮🇹
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italia, Italy

High-flow Nasal Cannula vs. Helmet PSV vs. Helmet CPAP During Respiratory Failure

Not Applicable

Completed

Conditions: Respiratory Failure
Hypoxemia

Interventions: Other: Respiratory support (High-flow oxygen therapy)
Other: Respiratory support (Helmet CPAP)
Other: Respiratory support (Helmet PSV)

First Posted Date: 2020-01-27

Last Posted Date: 2021-02-08

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 15

Registration Number: NCT04241861

Locations: 🇮🇹
Fondazione Policlinico Universitaro A. Gemelli IRCCS, Rome, Italy

Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Phase 2

Conditions: Locally Advanced Cervical Cancer

Interventions: Drug: Pembrolizumab
Drug: Carboplatin
Drug: Taxol

First Posted Date: 2020-01-23

Last Posted Date: 2021-08-27

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 45

Registration Number: NCT04238988

Locations: 🇮🇹
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions

Phase 2

Recruiting

Conditions: Cervical, Vaginal and Vulval Inflammatory Diseases

Interventions: Drug: Pembrolizumab

First Posted Date: 2019-12-26

Last Posted Date: 2021-08-27

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 45

Registration Number: NCT04211103

Locations: 🇮🇹
Ospedale "degli Infermi", Faenza, Italy
🇮🇹
Ospedale Santa Maria delle Croci, Ravenna, Italy
🇮🇹
Istituti fisioterapici Ospitalieri - Istituto Tumori Regina Elena, Rome, Italy

and more 6 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy